Effects of slow-loaded breathing training on resting blood pressure in essential hypertension Patients: A Randomized Controlled Trial

Not Applicable

Completed

• Conditions: essential hypertension; Physical Medicine / Rehabilitation - Physiotherapy; Cardiovascular - Hypertension

• Registration Number: ACTRN12624000558527
• Lead Sponsor: Faculty of Medicine, Prince of Songkla University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-10-12
• Study Start: 2024-05-02
• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Inclusion criteria were subjects aged 30 to 59 years were I to II stage of essential hypertension, defined as average SBP 140-179 mmHg and DBP 90-109 mmHg based on recommendation of JNC-VII (Chobanian AV et al. 2007) with stable controlled hypertension before the study, good communication and co-operation.

Exclusion Criteria

Exclusion criteria were secondary hypertension, use beta-blockers, heart disease (coronary artery disease, myocardial infarction, etc.), respiratory disease (asthma, chronic bronchitis), neuromuscular disease (muscle weakness, cerebrovascular disease, etc.), renal disease, metabolic syndrome, aortic aneurysm.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Resting blood pressure this will be assessed as a composite outcome (SBP, DBP, PP and MAP)[Resting blood pressure this will be assessed as a composite outcome (SBP, DBP, PP and MAP). All patients were used a digital upper arm blood pressure monitor (Microlife, BP 3BM1-3) with an appropriately sized cuff to measured home blood pressure: systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), and mean arterial pressure (MAP) in every morning before 9.00 am at sitting position after rest for least 15 minutes. Before the measurement patients were asked to refrain from caffeine or physical activity at least 30 minutes. Baseline and daily with average weekly measures assessed for each week of the intervention (8 weeks), final week averages will be primary timepoint]

Secondary Outcome Measures

Name	Time	Method
Resting heart rate (HR) [All patients were used a digital upper arm blood pressure monitor (Microlife, BP 3BM1-3) with an appropriately sized cuff to measured heart rate (HR) in every morning before 9.00 am at sitting position after rest for least 15 minutes. Before the measurement patients were asked to refrain from caffeine or physical activity at least 30 minutes. Baseline and daily for the length of the intervention (8 weeks)]